Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (6)
Type
(
1 selected
)
Type
Guidance (1898)
NICE advice (321)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (225)
COVID-19 rapid guidelines (3)
Diagnostics guidance (50)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (603)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (341)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (791)
Apply filters
Showing 721 to 730 of 1898
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer
TA638
1 July 2020
1 July 2020
Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer
TA639
1 July 2020
1 July 2020
Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma (terminated appraisal)
TA634
30 June 2020
30 June 2020
Ramucirumab with erlotinib for untreated EGFR-positive metastatic non-small-cell lung cancer (terminated appraisal)
TA635
30 June 2020
30 June 2020
Eculizumab for treating refractory myasthenia gravis (terminated appraisal)
TA636
30 June 2020
30 June 2020
Ranibizumab for treating diabetic retinopathy (terminated appraisal)
TA637
30 June 2020
30 June 2020
Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure
TA626
24 June 2020
24 June 2020
Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention
IPG673
24 June 2020
24 June 2020
Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia
MTG49
24 June 2020
24 June 2020
Ustekinumab for treating moderately to severely active ulcerative colitis
TA633
17 June 2020
17 June 2020
Previous page
1
…
71
72
Current page
73
74
75
…
190
Page
73
of
190
Next page
Results per page
10
25
50
All
Back to top